Skip to main content

UPDATE: NIH s Mammalian Gene Project to Use Agencourt s cDNA Technology

NEW YORK, Jan. 21 - Agencourt Bioscience is set to announce on Tuesday that it will provide genomic services to the Mammalian Gene Collection project of the National Institutes of Health.

Terms of the agreement, funded through a federal contract, call for Agencourt to use its Solid Phase Reversible Immobilization technology to sequence tag mammalian cDNAs and help MGC identify and sequence full-length cDNAs, according to Agencourt.

The project's goal is to identify and sequence a representative full open reading frame clone for each human and mouse gene to be used as a reference for genotyping and haplotyping. It is being carried out by a range of partners, including Clontech and Agencourt.

Although financial details of the deal are not known at this time, Agencourt said that all resources generated by the MGC project will be publicly accessible.

Agencourt, based in Beverly, Mass., provides DNA sequencing, DNA purification, and SNP genotyping services and products to companies in genomics research.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.